Identification of the novel HLA-DQB1*05:275 allele by next-generation sequencing.

Alleles Exons / genetics HLA-DQ beta-Chains / genetics High-Throughput Nucleotide Sequencing Humans
HLA HLA-DQB1*05:275 human leukocyte antigen next-generation sequencing novel allele

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
12 2021
Historique:
received: 10 05 2021
accepted: 11 05 2021
pubmed: 15 5 2021
medline: 29 4 2022
entrez: 14 5 2021
Statut: ppublish

Résumé

HLA-DQB1*05:275 differs from DQB1*05:01 by one nucleotide substitution in codon 224 in exon 4.

Identifiants

DOI: 10.1111/tan.14310 PMID: 33987978
pubmed: 33987978
doi: 10.1111/tan.14310
doi:

Substances chimiques

HLA-DQ beta-Chains 0
HLA-DQB1 antigen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

571-572

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA database. Nucleic Acids Res. 2020;48:D948-D955.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75:291-455.

Auteurs

Charlène Bouthemy (C)

CHU Toulouse, Laboratoire d'Immunologie, Institut Fédératif de Biologie, Hôpital Purpan, Toulouse, France.
ORCID: 0000-0002-0926-0445

Mamy Ralazamahaleo (M)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Place Amélie Raba Léon, Bordeaux, France.

Jonathan Visentin (J)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Place Amélie Raba Léon, Bordeaux, France.
ORCID: 0000-0003-3795-8979

Marylise Fort (M)

CHU Toulouse, Laboratoire d'Immunologie, Institut Fédératif de Biologie, Hôpital Purpan, Toulouse, France.

Nicolas Congy-Jolivet (N)

CHU Toulouse, Laboratoire d'Immunologie, Institut Fédératif de Biologie, Hôpital Purpan, Toulouse, France.

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Identification of the novel HLA-DQB1*05:275...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Composants de gène › Exons › Identification of the novel HLA-DQB1*05:275...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-D › Antigènes HLA-DQ › Chaines bêta des antigènes HLA-DQ › Identification of the novel HLA-DQB1*05:275...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Séquençage nucléotidique à haut débit › Identification of the novel HLA-DQB1*05:275...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Identification of the novel HLA-DQB1*05:275...